KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Other Working Capital Changes (2016 - 2025)

Nektar Therapeutics has reported Other Working Capital Changes over the past 16 years, most recently at $9.9 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $9.9 million for Q4 2025, up 306.35% from a year ago — trailing twelve months through Dec 2025 was $15.4 million (up 268.98% YoY), and the annual figure for FY2025 was $15.4 million, up 268.98%.
  • Other Working Capital Changes for Q4 2025 was $9.9 million at Nektar Therapeutics, up from $618000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for NKTR hit a ceiling of $10.8 million in Q3 2021 and a floor of -$6.2 million in Q1 2021.
  • Median Other Working Capital Changes over the past 5 years was $742500.0 (2023), compared with a mean of $586650.0.
  • Biggest five-year swings in Other Working Capital Changes: crashed 160.15% in 2022 and later surged 510.45% in 2025.
  • Nektar Therapeutics' Other Working Capital Changes stood at $3.4 million in 2021, then crashed by 160.15% to -$2.0 million in 2022, then soared by 142.4% to $867000.0 in 2023, then soared by 179.82% to $2.4 million in 2024, then skyrocketed by 306.35% to $9.9 million in 2025.
  • The last three reported values for Other Working Capital Changes were $9.9 million (Q4 2025), $618000.0 (Q3 2025), and -$985000.0 (Q2 2025) per Business Quant data.